Pharma & Healthcare
Global Drugs for Vaginal Fungal Infections Market Research Report 2025
- May 28, 25
- ID: 277382
- Pages: 93
- Figures: 96
- Views: 3
The global market for Drugs for Vaginal Fungal Infections was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Vaginal Fungal Infections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Vaginal Fungal Infections.
The Drugs for Vaginal Fungal Infections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Vaginal Fungal Infections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Vaginal Fungal Infections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Bausch Health Companies Inc
ANl Pharmaceuticals, Inc
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC Medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS,Inc.
Basilea Pharmaceutica Ltd.
Astellas Pharma lnc.
Grupo Ferrer Internacional,S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc.
Cidara Therapeutics, Inc.
Amplyx Pharmaceuticals Inc.
Segment by Type
Fluconazole
Nystatin
Flucytosine
Clotrimazole
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Vaginal Fungal Infections company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Vaginal Fungal Infections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Vaginal Fungal Infections.
The Drugs for Vaginal Fungal Infections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Vaginal Fungal Infections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Vaginal Fungal Infections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Bausch Health Companies Inc
ANl Pharmaceuticals, Inc
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC Medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS,Inc.
Basilea Pharmaceutica Ltd.
Astellas Pharma lnc.
Grupo Ferrer Internacional,S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc.
Cidara Therapeutics, Inc.
Amplyx Pharmaceuticals Inc.
Segment by Type
Fluconazole
Nystatin
Flucytosine
Clotrimazole
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Vaginal Fungal Infections company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluconazole
1.2.3 Nystatin
1.2.4 Flucytosine
1.2.5 Clotrimazole
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drugs for Vaginal Fungal Infections Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Vaginal Fungal Infections Market Perspective (2020-2031)
2.2 Global Drugs for Vaginal Fungal Infections Growth Trends by Region
2.2.1 Global Drugs for Vaginal Fungal Infections Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Vaginal Fungal Infections Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Vaginal Fungal Infections Market Dynamics
2.3.1 Drugs for Vaginal Fungal Infections Industry Trends
2.3.2 Drugs for Vaginal Fungal Infections Market Drivers
2.3.3 Drugs for Vaginal Fungal Infections Market Challenges
2.3.4 Drugs for Vaginal Fungal Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue
3.1.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue (2020-2025)
3.1.2 Global Drugs for Vaginal Fungal Infections Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Vaginal Fungal Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Vaginal Fungal Infections Revenue
3.4 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio
3.4.1 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Vaginal Fungal Infections Revenue in 2024
3.5 Global Key Players of Drugs for Vaginal Fungal Infections Head office and Area Served
3.6 Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
3.7 Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Vaginal Fungal Infections Breakdown Data by Type
4.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031)
5 Drugs for Vaginal Fungal Infections Breakdown Data by Application
5.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
6.2 North America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
6.4 North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Vaginal Fungal Infections Market Size (2020-2031)
7.2 Europe Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
7.4 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Vaginal Fungal Infections Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
9.2 Latin America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
9.4 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Drugs for Vaginal Fungal Infections Introduction
11.1.4 Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Details
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Introduction
11.2.4 Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 ANl Pharmaceuticals, Inc
11.3.1 ANl Pharmaceuticals, Inc Company Details
11.3.2 ANl Pharmaceuticals, Inc Business Overview
11.3.3 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Introduction
11.3.4 ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.3.5 ANl Pharmaceuticals, Inc Recent Development
11.4 Hikma Pharmaceuticals Plc
11.4.1 Hikma Pharmaceuticals Plc Company Details
11.4.2 Hikma Pharmaceuticals Plc Business Overview
11.4.3 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Introduction
11.4.4 Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.4.5 Hikma Pharmaceuticals Plc Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Drugs for Vaginal Fungal Infections Introduction
11.5.4 Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.5.5 Lupin Limited Recent Development
11.6 Mycovia Pharmaceuticals, Inc.
11.6.1 Mycovia Pharmaceuticals, Inc. Company Details
11.6.2 Mycovia Pharmaceuticals, Inc. Business Overview
11.6.3 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Introduction
11.6.4 Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.6.5 Mycovia Pharmaceuticals, Inc. Recent Development
11.7 Glenmark Pharmaceuticals Limited
11.7.1 Glenmark Pharmaceuticals Limited Company Details
11.7.2 Glenmark Pharmaceuticals Limited Business Overview
11.7.3 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Introduction
11.7.4 Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.7.5 Glenmark Pharmaceuticals Limited Recent Development
11.8 Unique Pharmaceuticals
11.8.1 Unique Pharmaceuticals Company Details
11.8.2 Unique Pharmaceuticals Business Overview
11.8.3 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Introduction
11.8.4 Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.8.5 Unique Pharmaceuticals Recent Development
11.9 PEPTONIC Medical AB
11.9.1 PEPTONIC Medical AB Company Details
11.9.2 PEPTONIC Medical AB Business Overview
11.9.3 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Introduction
11.9.4 PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.9.5 PEPTONIC Medical AB Recent Development
11.10 Aurobindo Pharma Limited
11.10.1 Aurobindo Pharma Limited Company Details
11.10.2 Aurobindo Pharma Limited Business Overview
11.10.3 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Introduction
11.10.4 Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.10.5 Aurobindo Pharma Limited Recent Development
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Details
11.11.2 Dr. Reddy's Laboratories Business Overview
11.11.3 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Introduction
11.11.4 Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.11.5 Dr. Reddy's Laboratories Recent Development
11.12 SCYNEXIS,Inc.
11.12.1 SCYNEXIS,Inc. Company Details
11.12.2 SCYNEXIS,Inc. Business Overview
11.12.3 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Introduction
11.12.4 SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.12.5 SCYNEXIS,Inc. Recent Development
11.13 Basilea Pharmaceutica Ltd.
11.13.1 Basilea Pharmaceutica Ltd. Company Details
11.13.2 Basilea Pharmaceutica Ltd. Business Overview
11.13.3 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Introduction
11.13.4 Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.13.5 Basilea Pharmaceutica Ltd. Recent Development
11.14 Astellas Pharma lnc.
11.14.1 Astellas Pharma lnc. Company Details
11.14.2 Astellas Pharma lnc. Business Overview
11.14.3 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Introduction
11.14.4 Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.14.5 Astellas Pharma lnc. Recent Development
11.15 Grupo Ferrer Internacional,S.A.
11.15.1 Grupo Ferrer Internacional,S.A. Company Details
11.15.2 Grupo Ferrer Internacional,S.A. Business Overview
11.15.3 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Introduction
11.15.4 Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.15.5 Grupo Ferrer Internacional,S.A. Recent Development
11.16 Pacgen Life Science Corporation
11.16.1 Pacgen Life Science Corporation Company Details
11.16.2 Pacgen Life Science Corporation Business Overview
11.16.3 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Introduction
11.16.4 Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.16.5 Pacgen Life Science Corporation Recent Development
11.17 NovaDigm Therapeutics, Inc.
11.17.1 NovaDigm Therapeutics, Inc. Company Details
11.17.2 NovaDigm Therapeutics, Inc. Business Overview
11.17.3 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.17.4 NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.17.5 NovaDigm Therapeutics, Inc. Recent Development
11.18 Cidara Therapeutics, Inc.
11.18.1 Cidara Therapeutics, Inc. Company Details
11.18.2 Cidara Therapeutics, Inc. Business Overview
11.18.3 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.18.4 Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.18.5 Cidara Therapeutics, Inc. Recent Development
11.19 Amplyx Pharmaceuticals Inc.
11.19.1 Amplyx Pharmaceuticals Inc. Company Details
11.19.2 Amplyx Pharmaceuticals Inc. Business Overview
11.19.3 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Introduction
11.19.4 Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.19.5 Amplyx Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluconazole
1.2.3 Nystatin
1.2.4 Flucytosine
1.2.5 Clotrimazole
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drugs for Vaginal Fungal Infections Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Vaginal Fungal Infections Market Perspective (2020-2031)
2.2 Global Drugs for Vaginal Fungal Infections Growth Trends by Region
2.2.1 Global Drugs for Vaginal Fungal Infections Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Vaginal Fungal Infections Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Vaginal Fungal Infections Market Dynamics
2.3.1 Drugs for Vaginal Fungal Infections Industry Trends
2.3.2 Drugs for Vaginal Fungal Infections Market Drivers
2.3.3 Drugs for Vaginal Fungal Infections Market Challenges
2.3.4 Drugs for Vaginal Fungal Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue
3.1.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue (2020-2025)
3.1.2 Global Drugs for Vaginal Fungal Infections Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Vaginal Fungal Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Vaginal Fungal Infections Revenue
3.4 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio
3.4.1 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Vaginal Fungal Infections Revenue in 2024
3.5 Global Key Players of Drugs for Vaginal Fungal Infections Head office and Area Served
3.6 Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
3.7 Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Vaginal Fungal Infections Breakdown Data by Type
4.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031)
5 Drugs for Vaginal Fungal Infections Breakdown Data by Application
5.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
6.2 North America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
6.4 North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Vaginal Fungal Infections Market Size (2020-2031)
7.2 Europe Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
7.4 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Vaginal Fungal Infections Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
9.2 Latin America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
9.4 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Drugs for Vaginal Fungal Infections Introduction
11.1.4 Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Details
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Introduction
11.2.4 Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 ANl Pharmaceuticals, Inc
11.3.1 ANl Pharmaceuticals, Inc Company Details
11.3.2 ANl Pharmaceuticals, Inc Business Overview
11.3.3 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Introduction
11.3.4 ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.3.5 ANl Pharmaceuticals, Inc Recent Development
11.4 Hikma Pharmaceuticals Plc
11.4.1 Hikma Pharmaceuticals Plc Company Details
11.4.2 Hikma Pharmaceuticals Plc Business Overview
11.4.3 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Introduction
11.4.4 Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.4.5 Hikma Pharmaceuticals Plc Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Drugs for Vaginal Fungal Infections Introduction
11.5.4 Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.5.5 Lupin Limited Recent Development
11.6 Mycovia Pharmaceuticals, Inc.
11.6.1 Mycovia Pharmaceuticals, Inc. Company Details
11.6.2 Mycovia Pharmaceuticals, Inc. Business Overview
11.6.3 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Introduction
11.6.4 Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.6.5 Mycovia Pharmaceuticals, Inc. Recent Development
11.7 Glenmark Pharmaceuticals Limited
11.7.1 Glenmark Pharmaceuticals Limited Company Details
11.7.2 Glenmark Pharmaceuticals Limited Business Overview
11.7.3 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Introduction
11.7.4 Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.7.5 Glenmark Pharmaceuticals Limited Recent Development
11.8 Unique Pharmaceuticals
11.8.1 Unique Pharmaceuticals Company Details
11.8.2 Unique Pharmaceuticals Business Overview
11.8.3 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Introduction
11.8.4 Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.8.5 Unique Pharmaceuticals Recent Development
11.9 PEPTONIC Medical AB
11.9.1 PEPTONIC Medical AB Company Details
11.9.2 PEPTONIC Medical AB Business Overview
11.9.3 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Introduction
11.9.4 PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.9.5 PEPTONIC Medical AB Recent Development
11.10 Aurobindo Pharma Limited
11.10.1 Aurobindo Pharma Limited Company Details
11.10.2 Aurobindo Pharma Limited Business Overview
11.10.3 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Introduction
11.10.4 Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.10.5 Aurobindo Pharma Limited Recent Development
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Details
11.11.2 Dr. Reddy's Laboratories Business Overview
11.11.3 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Introduction
11.11.4 Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.11.5 Dr. Reddy's Laboratories Recent Development
11.12 SCYNEXIS,Inc.
11.12.1 SCYNEXIS,Inc. Company Details
11.12.2 SCYNEXIS,Inc. Business Overview
11.12.3 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Introduction
11.12.4 SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.12.5 SCYNEXIS,Inc. Recent Development
11.13 Basilea Pharmaceutica Ltd.
11.13.1 Basilea Pharmaceutica Ltd. Company Details
11.13.2 Basilea Pharmaceutica Ltd. Business Overview
11.13.3 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Introduction
11.13.4 Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.13.5 Basilea Pharmaceutica Ltd. Recent Development
11.14 Astellas Pharma lnc.
11.14.1 Astellas Pharma lnc. Company Details
11.14.2 Astellas Pharma lnc. Business Overview
11.14.3 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Introduction
11.14.4 Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.14.5 Astellas Pharma lnc. Recent Development
11.15 Grupo Ferrer Internacional,S.A.
11.15.1 Grupo Ferrer Internacional,S.A. Company Details
11.15.2 Grupo Ferrer Internacional,S.A. Business Overview
11.15.3 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Introduction
11.15.4 Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.15.5 Grupo Ferrer Internacional,S.A. Recent Development
11.16 Pacgen Life Science Corporation
11.16.1 Pacgen Life Science Corporation Company Details
11.16.2 Pacgen Life Science Corporation Business Overview
11.16.3 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Introduction
11.16.4 Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.16.5 Pacgen Life Science Corporation Recent Development
11.17 NovaDigm Therapeutics, Inc.
11.17.1 NovaDigm Therapeutics, Inc. Company Details
11.17.2 NovaDigm Therapeutics, Inc. Business Overview
11.17.3 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.17.4 NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.17.5 NovaDigm Therapeutics, Inc. Recent Development
11.18 Cidara Therapeutics, Inc.
11.18.1 Cidara Therapeutics, Inc. Company Details
11.18.2 Cidara Therapeutics, Inc. Business Overview
11.18.3 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.18.4 Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.18.5 Cidara Therapeutics, Inc. Recent Development
11.19 Amplyx Pharmaceuticals Inc.
11.19.1 Amplyx Pharmaceuticals Inc. Company Details
11.19.2 Amplyx Pharmaceuticals Inc. Business Overview
11.19.3 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Introduction
11.19.4 Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.19.5 Amplyx Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fluconazole
Table 3. Key Players of Nystatin
Table 4. Key Players of Flucytosine
Table 5. Key Players of Clotrimazole
Table 6. Key Players of Others
Table 7. Global Drugs for Vaginal Fungal Infections Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Drugs for Vaginal Fungal Infections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Drugs for Vaginal Fungal Infections Market Share by Region (2020-2025)
Table 11. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Drugs for Vaginal Fungal Infections Market Share by Region (2026-2031)
Table 13. Drugs for Vaginal Fungal Infections Market Trends
Table 14. Drugs for Vaginal Fungal Infections Market Drivers
Table 15. Drugs for Vaginal Fungal Infections Market Challenges
Table 16. Drugs for Vaginal Fungal Infections Market Restraints
Table 17. Global Drugs for Vaginal Fungal Infections Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Drugs for Vaginal Fungal Infections Market Share by Players (2020-2025)
Table 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
Table 20. Ranking of Global Top Drugs for Vaginal Fungal Infections Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Drugs for Vaginal Fungal Infections Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Drugs for Vaginal Fungal Infections, Headquarters and Area Served
Table 23. Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
Table 24. Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2020-2025)
Table 28. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2026-2031)
Table 30. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2020-2025)
Table 32. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2026-2031)
Table 34. North America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 49. Pfizer Inc. Company Details
Table 50. Pfizer Inc. Business Overview
Table 51. Pfizer Inc. Drugs for Vaginal Fungal Infections Product
Table 52. Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 53. Pfizer Inc. Recent Development
Table 54. Bausch Health Companies Inc Company Details
Table 55. Bausch Health Companies Inc Business Overview
Table 56. Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Product
Table 57. Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 58. Bausch Health Companies Inc Recent Development
Table 59. ANl Pharmaceuticals, Inc Company Details
Table 60. ANl Pharmaceuticals, Inc Business Overview
Table 61. ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Product
Table 62. ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 63. ANl Pharmaceuticals, Inc Recent Development
Table 64. Hikma Pharmaceuticals Plc Company Details
Table 65. Hikma Pharmaceuticals Plc Business Overview
Table 66. Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Product
Table 67. Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 68. Hikma Pharmaceuticals Plc Recent Development
Table 69. Lupin Limited Company Details
Table 70. Lupin Limited Business Overview
Table 71. Lupin Limited Drugs for Vaginal Fungal Infections Product
Table 72. Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 73. Lupin Limited Recent Development
Table 74. Mycovia Pharmaceuticals, Inc. Company Details
Table 75. Mycovia Pharmaceuticals, Inc. Business Overview
Table 76. Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Product
Table 77. Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 78. Mycovia Pharmaceuticals, Inc. Recent Development
Table 79. Glenmark Pharmaceuticals Limited Company Details
Table 80. Glenmark Pharmaceuticals Limited Business Overview
Table 81. Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Product
Table 82. Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 83. Glenmark Pharmaceuticals Limited Recent Development
Table 84. Unique Pharmaceuticals Company Details
Table 85. Unique Pharmaceuticals Business Overview
Table 86. Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Product
Table 87. Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 88. Unique Pharmaceuticals Recent Development
Table 89. PEPTONIC Medical AB Company Details
Table 90. PEPTONIC Medical AB Business Overview
Table 91. PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Product
Table 92. PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 93. PEPTONIC Medical AB Recent Development
Table 94. Aurobindo Pharma Limited Company Details
Table 95. Aurobindo Pharma Limited Business Overview
Table 96. Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Product
Table 97. Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 98. Aurobindo Pharma Limited Recent Development
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Development
Table 104. SCYNEXIS,Inc. Company Details
Table 105. SCYNEXIS,Inc. Business Overview
Table 106. SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Product
Table 107. SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 108. SCYNEXIS,Inc. Recent Development
Table 109. Basilea Pharmaceutica Ltd. Company Details
Table 110. Basilea Pharmaceutica Ltd. Business Overview
Table 111. Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Product
Table 112. Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 113. Basilea Pharmaceutica Ltd. Recent Development
Table 114. Astellas Pharma lnc. Company Details
Table 115. Astellas Pharma lnc. Business Overview
Table 116. Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Product
Table 117. Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 118. Astellas Pharma lnc. Recent Development
Table 119. Grupo Ferrer Internacional,S.A. Company Details
Table 120. Grupo Ferrer Internacional,S.A. Business Overview
Table 121. Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Product
Table 122. Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 123. Grupo Ferrer Internacional,S.A. Recent Development
Table 124. Pacgen Life Science Corporation Company Details
Table 125. Pacgen Life Science Corporation Business Overview
Table 126. Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Product
Table 127. Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 128. Pacgen Life Science Corporation Recent Development
Table 129. NovaDigm Therapeutics, Inc. Company Details
Table 130. NovaDigm Therapeutics, Inc. Business Overview
Table 131. NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
Table 132. NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 133. NovaDigm Therapeutics, Inc. Recent Development
Table 134. Cidara Therapeutics, Inc. Company Details
Table 135. Cidara Therapeutics, Inc. Business Overview
Table 136. Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
Table 137. Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 138. Cidara Therapeutics, Inc. Recent Development
Table 139. Amplyx Pharmaceuticals Inc. Company Details
Table 140. Amplyx Pharmaceuticals Inc. Business Overview
Table 141. Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Product
Table 142. Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 143. Amplyx Pharmaceuticals Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Drugs for Vaginal Fungal Infections Picture
Figure 2. Global Drugs for Vaginal Fungal Infections Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Vaginal Fungal Infections Market Share by Type: 2024 VS 2031
Figure 4. Fluconazole Features
Figure 5. Nystatin Features
Figure 6. Flucytosine Features
Figure 7. Clotrimazole Features
Figure 8. Others Features
Figure 9. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Drugs for Vaginal Fungal Infections Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Drugs for Vaginal Fungal Infections Report Years Considered
Figure 15. Global Drugs for Vaginal Fungal Infections Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Drugs for Vaginal Fungal Infections Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drugs for Vaginal Fungal Infections Market Share by Region: 2024 VS 2031
Figure 18. Global Drugs for Vaginal Fungal Infections Market Share by Players in 2024
Figure 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Drugs for Vaginal Fungal Infections Revenue in 2024
Figure 21. North America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 23. United States Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 27. Germany Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Drugs for Vaginal Fungal Infections Market Share by Region (2020-2031)
Figure 35. China Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 43. Mexico Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 47. Turkey Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 51. Bausch Health Companies Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 52. ANl Pharmaceuticals, Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 53. Hikma Pharmaceuticals Plc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 54. Lupin Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 55. Mycovia Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 56. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 57. Unique Pharmaceuticals Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 58. PEPTONIC Medical AB Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 59. Aurobindo Pharma Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 61. SCYNEXIS,Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 62. Basilea Pharmaceutica Ltd. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 63. Astellas Pharma lnc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 64. Grupo Ferrer Internacional,S.A. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 65. Pacgen Life Science Corporation Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 66. NovaDigm Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 67. Cidara Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 68. Amplyx Pharmaceuticals Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fluconazole
Table 3. Key Players of Nystatin
Table 4. Key Players of Flucytosine
Table 5. Key Players of Clotrimazole
Table 6. Key Players of Others
Table 7. Global Drugs for Vaginal Fungal Infections Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Drugs for Vaginal Fungal Infections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Drugs for Vaginal Fungal Infections Market Share by Region (2020-2025)
Table 11. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Drugs for Vaginal Fungal Infections Market Share by Region (2026-2031)
Table 13. Drugs for Vaginal Fungal Infections Market Trends
Table 14. Drugs for Vaginal Fungal Infections Market Drivers
Table 15. Drugs for Vaginal Fungal Infections Market Challenges
Table 16. Drugs for Vaginal Fungal Infections Market Restraints
Table 17. Global Drugs for Vaginal Fungal Infections Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Drugs for Vaginal Fungal Infections Market Share by Players (2020-2025)
Table 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
Table 20. Ranking of Global Top Drugs for Vaginal Fungal Infections Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Drugs for Vaginal Fungal Infections Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Drugs for Vaginal Fungal Infections, Headquarters and Area Served
Table 23. Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
Table 24. Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2020-2025)
Table 28. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2026-2031)
Table 30. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2020-2025)
Table 32. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2026-2031)
Table 34. North America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
Table 49. Pfizer Inc. Company Details
Table 50. Pfizer Inc. Business Overview
Table 51. Pfizer Inc. Drugs for Vaginal Fungal Infections Product
Table 52. Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 53. Pfizer Inc. Recent Development
Table 54. Bausch Health Companies Inc Company Details
Table 55. Bausch Health Companies Inc Business Overview
Table 56. Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Product
Table 57. Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 58. Bausch Health Companies Inc Recent Development
Table 59. ANl Pharmaceuticals, Inc Company Details
Table 60. ANl Pharmaceuticals, Inc Business Overview
Table 61. ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Product
Table 62. ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 63. ANl Pharmaceuticals, Inc Recent Development
Table 64. Hikma Pharmaceuticals Plc Company Details
Table 65. Hikma Pharmaceuticals Plc Business Overview
Table 66. Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Product
Table 67. Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 68. Hikma Pharmaceuticals Plc Recent Development
Table 69. Lupin Limited Company Details
Table 70. Lupin Limited Business Overview
Table 71. Lupin Limited Drugs for Vaginal Fungal Infections Product
Table 72. Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 73. Lupin Limited Recent Development
Table 74. Mycovia Pharmaceuticals, Inc. Company Details
Table 75. Mycovia Pharmaceuticals, Inc. Business Overview
Table 76. Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Product
Table 77. Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 78. Mycovia Pharmaceuticals, Inc. Recent Development
Table 79. Glenmark Pharmaceuticals Limited Company Details
Table 80. Glenmark Pharmaceuticals Limited Business Overview
Table 81. Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Product
Table 82. Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 83. Glenmark Pharmaceuticals Limited Recent Development
Table 84. Unique Pharmaceuticals Company Details
Table 85. Unique Pharmaceuticals Business Overview
Table 86. Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Product
Table 87. Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 88. Unique Pharmaceuticals Recent Development
Table 89. PEPTONIC Medical AB Company Details
Table 90. PEPTONIC Medical AB Business Overview
Table 91. PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Product
Table 92. PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 93. PEPTONIC Medical AB Recent Development
Table 94. Aurobindo Pharma Limited Company Details
Table 95. Aurobindo Pharma Limited Business Overview
Table 96. Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Product
Table 97. Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 98. Aurobindo Pharma Limited Recent Development
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Development
Table 104. SCYNEXIS,Inc. Company Details
Table 105. SCYNEXIS,Inc. Business Overview
Table 106. SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Product
Table 107. SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 108. SCYNEXIS,Inc. Recent Development
Table 109. Basilea Pharmaceutica Ltd. Company Details
Table 110. Basilea Pharmaceutica Ltd. Business Overview
Table 111. Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Product
Table 112. Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 113. Basilea Pharmaceutica Ltd. Recent Development
Table 114. Astellas Pharma lnc. Company Details
Table 115. Astellas Pharma lnc. Business Overview
Table 116. Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Product
Table 117. Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 118. Astellas Pharma lnc. Recent Development
Table 119. Grupo Ferrer Internacional,S.A. Company Details
Table 120. Grupo Ferrer Internacional,S.A. Business Overview
Table 121. Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Product
Table 122. Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 123. Grupo Ferrer Internacional,S.A. Recent Development
Table 124. Pacgen Life Science Corporation Company Details
Table 125. Pacgen Life Science Corporation Business Overview
Table 126. Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Product
Table 127. Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 128. Pacgen Life Science Corporation Recent Development
Table 129. NovaDigm Therapeutics, Inc. Company Details
Table 130. NovaDigm Therapeutics, Inc. Business Overview
Table 131. NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
Table 132. NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 133. NovaDigm Therapeutics, Inc. Recent Development
Table 134. Cidara Therapeutics, Inc. Company Details
Table 135. Cidara Therapeutics, Inc. Business Overview
Table 136. Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
Table 137. Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 138. Cidara Therapeutics, Inc. Recent Development
Table 139. Amplyx Pharmaceuticals Inc. Company Details
Table 140. Amplyx Pharmaceuticals Inc. Business Overview
Table 141. Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Product
Table 142. Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
Table 143. Amplyx Pharmaceuticals Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Drugs for Vaginal Fungal Infections Picture
Figure 2. Global Drugs for Vaginal Fungal Infections Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Vaginal Fungal Infections Market Share by Type: 2024 VS 2031
Figure 4. Fluconazole Features
Figure 5. Nystatin Features
Figure 6. Flucytosine Features
Figure 7. Clotrimazole Features
Figure 8. Others Features
Figure 9. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Drugs for Vaginal Fungal Infections Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Drugs for Vaginal Fungal Infections Report Years Considered
Figure 15. Global Drugs for Vaginal Fungal Infections Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Drugs for Vaginal Fungal Infections Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drugs for Vaginal Fungal Infections Market Share by Region: 2024 VS 2031
Figure 18. Global Drugs for Vaginal Fungal Infections Market Share by Players in 2024
Figure 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Drugs for Vaginal Fungal Infections Revenue in 2024
Figure 21. North America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 23. United States Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 27. Germany Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Drugs for Vaginal Fungal Infections Market Share by Region (2020-2031)
Figure 35. China Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 43. Mexico Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
Figure 47. Turkey Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 51. Bausch Health Companies Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 52. ANl Pharmaceuticals, Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 53. Hikma Pharmaceuticals Plc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 54. Lupin Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 55. Mycovia Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 56. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 57. Unique Pharmaceuticals Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 58. PEPTONIC Medical AB Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 59. Aurobindo Pharma Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 61. SCYNEXIS,Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 62. Basilea Pharmaceutica Ltd. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 63. Astellas Pharma lnc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 64. Grupo Ferrer Internacional,S.A. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 65. Pacgen Life Science Corporation Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 66. NovaDigm Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 67. Cidara Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 68. Amplyx Pharmaceuticals Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232